ATLAS PERFORMANCE
The Tesamorelin
Research Deep-Dive
An FDA-approved peptide — with a label that tells the real story.
A free 5-page PDF — no hype, just the studies.
What’s inside
- What tesamorelin is — the stabilized GHRH analog, and the problem it was built for
- The Phase 3 trial record — 816 patients, 14–18% visceral-fat reduction, in plain English
- Where the label stops — what’s not approved, stated honestly
- Safety notes — what the trials showed, including the unknowns
- The timeline — from 2005 Phase 2 data to the 2010 FDA approval and beyond
Educational research summary only — not medical advice.
All Atlas Performance products are intended for research and identification purposes only.
[tesa_form]
All products sold on this website are intended for research and identification purposes only.